Novo Nordisk is gearing up to pursue yet another indication for its star GLP-1 medicine semaglutide. In the phase 3 Essence trial, a once-weekly dose of semaglutide 2.4 mg helped to improve liver ...

GemVax’s phase 2a study ran for 24 weeks and enrolled 78 patients with PSP across five centers in Korea. Patients received either placebo, GV1001 0.56 mg or GV1001 1.12 mg, the company said.

The phase 1, open label clinical study is designed to enroll up to 10 participants and is being conducted in Johannesburg, Pretoria, and Bloemfontein, South Africa. This is the first cellular ...

Carol (Jones) Ridens Atkins went peacefully to be with her Lord and Savior on Sunday, October 13th. Carol was born on Christmas Day to Sam and Johnnie Rebecca (Roach) Jones. She was a third ...

The U.S. Space Force has awarded two task orders worth $733.6 million combined to SpaceX to provide Lane 1 launch services as part of the third phase of the National Security Space Launch program.

"Instead of looking at AD just through the usual lens of plaques and tangles, we focused on how specific cell types were changed in each phase," study author Dr. Kyle Travaglini, Ph.D., a ...

To help you start things off, we’ve summarized three famous recipes below (along with a copycat version of a fourth) and provided links where you can find instructions and details. Provided by ...

Bluepoch Games announced phase 2 of Reverse: 1999 Version 1.9 is now live alongside the new Steam version. The update introduces six-star character Kakania, new first anniversary events, and much more ...

Reddy’s Laboratories Limited and a clinical stage biotech committed to bringing in novel and effective therapeutics for the treatment of cancer, has announced the Phase 1 results for ...

You can craft ANYTHING in Minecraft 1.14 with the new update...including the Bat Ears helmet and new Evoker Staff!PLAY my NEW Minecraft Game <a href="http://bit.ly ...

--(BUSINESS WIRE)--Septerna, a clinical-stage biotechnology company pioneering a new era of GPCR-targeted drug discovery, today announced the dosing of the first participants in its Phase 1 ...